Article

  • The EMBO Journal (2008) 27, 224 - 233
  • doi:10.1038/sj.emboj.7601953

Published online: 6 December 2007

Lipids revert inert Abold beta amyloid fibrils to neurotoxic protofibrils that affect learning in miceEMBO Open

Ivo Cristiano Martins1,5, Inna Kuperstein2,5, Hannah Wilkinson1, Elke Maes2, Mieke Vanbrabant2, Wim Jonckheere1, Patrick Van Gelder3, Dieter Hartmann2, Rudi D'Hooge4, Bart De Strooper2, Joost Schymkowitz1 and Frederic Rousseau1

  1. Switch Laboratory, Flanders Institute for Biotechnology (VIB) and Vrije Universiteit Brussel (VUB), Brussel, Belgium
  2. Laboratory for Neuronal Cell Biology and Gene Transfer, Center for Human Genetics, Flanders Institute for Biotechnology (VIB) and KULeuven, Leuven, Belgium
  3. ULTR Laboratory, Department for Molecular and Cellular Interactions, Flanders Institute for Biotechnology (VIB) and Vrije Universiteit Brussel (VUB), Brussel, Belgium
  4. Laboratory of Biological Psychology, KULeuven, Leuven, Belgium

Correspondence to:

Bart De Strooper, Laboratory for Neuronal Cell Biology and Gene Transfer, Center for Human Genetics, Flanders Institute for Biotechnology (VIB) and KULeuven, Herestraat 49, Leuven, Belgium. Tel.: +3216346227; Fax: +3216347181; E-mail: bart.destrooper@med.kuleuven.be

Joost Schymkowitz, Switch Laboratory, Flanders Institute for Biotechnology (VIB) and Vrije Universiteit Brussel (VUB), Pleinlaan 2, Brussel 1050, Belgium. Tel.: +3226291425; Fax: +3226291963; E-mail: joost.schymkowitz@vub.ac.be

Frederic Rousseau, Switch Laboratory, Flanders Institute for Biotechnology (VIB) and Vrije Universiteit Brussel (VUB), Pleinlaan 2, Brussel 1050, Belgium. Tel.: +3226291425; Fax: +3226291963; E-mail: frederic.rousseau@vub.ac.be

5These authors contributed equally to this work

Received 14 July 2007; Accepted 19 November 2007


Although soluble oligomeric and protofibrillar assemblies of Abeta-amyloid peptide cause synaptotoxicity and potentially contribute to Alzheimer's disease (AD), the role of mature Abeta-fibrils in the amyloid plaques remains controversial. A widely held view in the field suggests that the fibrillization reaction proceeds 'forward' in a near-irreversible manner from the monomeric Abeta peptide through toxic protofibrillar intermediates, which subsequently mature into biologically inert amyloid fibrils that are found in plaques. Here, we show that natural lipids destabilize and rapidly resolubilize mature Abeta amyloid fibers. Interestingly, the equilibrium is not reversed toward monomeric Abeta but rather toward soluble amyloid protofibrils. We characterized these 'backward' Abeta protofibrils generated from mature Abeta fibers and compared them with previously identified 'forward' Abeta protofibrils obtained from the aggregation of fresh Abeta monomers. We find that backward protofibrils are biochemically and biophysically very similar to forward protofibrils: they consist of a wide range of molecular masses, are toxic to primary neurons and cause memory impairment and tau phosphorylation in mouse. In addition, they diffuse rapidly through the brain into areas relevant to AD. Our findings imply that amyloid plaques are potentially major sources of soluble toxic Abeta-aggregates that could readily be activated by exposure to biological lipids.

  • Keywords:

    • Alzheimer's disease,
    • amyloid fibril,
    • amyloidosis,
    • lipid

This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits distribution, and reproduction in any medium, provided the original author and source are credited. This license does not permit commercial exploitation or the creation of derivative works without specific permission.

Top

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated

REVIEWS

What is the role of protein aggregation in neurodegeneration?

Nature Reviews Molecular Cell Biology Perspective (01 Nov 2005)

See all 29 matches for Reviews

NEWS AND VIEWS

Aβ star: a light onto synaptic dysfunction?

Nature Medicine News and Views (01 Jul 2006)

Alzheimer's disease A needle from the haystack

Nature News and Views (16 Mar 2006)

See all 7 matches for News And Views

The EMBO Journal is published by Nature Publishing Group on behalf of European Molecular Biology Organization